Facilitating enhanced 3D visualization of skeletal anatomy, the BoneEnhance machine learning module reportedly provides automated segmentation of bone and surrounding tissues for the Accuro XV ultrasound system.
|Articles|February 5, 1997
FDA clears Toshiba’s DCA technique
Toshiba America Medical Systems of Tustin, CA, has received 510(k)clearance for its Directional Color Angio (DCA) technique forthe PowerVision ultrasound scanner (SCAN Special Report 12/96).DCA combines color ultrasound angio images with directional
Advertisement
Toshiba America Medical Systems of Tustin, CA, has received 510(k)clearance for its Directional Color Angio (DCA) technique forthe PowerVision ultrasound scanner (SCAN Special Report 12/96).DCA combines color ultrasound angio images with directional blood-flowinformation from conventional color Doppler, allowing cliniciansto determine tissue perfusion and differentiate between arterialand venous blood flow. DCA is a standard feature on PowerVisionscanners.
Advertisement
Related to this article
Newly published preclinical research signals a substantial conceptual shift with a potential role of photon-counting CT in targeting specific biological processes.
The future of AI in radiology lies in its potential capability to forge connections and enhance efficiencies for enterprise-wide workflows.
In a new podcast episode, Joseph Cavallo, MD, MBA, offered his perspective on AI integration, potential efficiency gains, navigating post-deployment monitoring and how to incorporate AI literacy into radiology resident training.
The FFR-IQ software recently demonstrated a 92.2 percent sensitivity for non-invasive estimation of fractional flow reserve (FFRC) based on coronary CT angiography (CCTA) scans.
A Kaiser score > 5 with breast MRI demonstrated a 97 percent sensitivity and 87.9 percent specificity for predicting malignancy in patients with BI-RADS 0 or 4 presentations on mammography and breast ultrasound, according to a new study.
In a recent interview, Francesco Giganti, MD, PhD, discussed findings from a recent multicenter study demonstrating the ability of an AI software to provide significant clarity to initial PI-RADS 3 assessments on MRI and facilitate a nearly 19 percent reduction in unnecessary prostate biopsies.
The NEXT-Cue AI software, which incorporates analysis of brain MRI scans, reportedly facilitates prognostic assessments of potential progression from mild cognitive impairment (MCI) to Alzheimer’s disease within five years.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Could Photon-Counting CT Have an Impact as a Platform for Molecular Imaging?
2
What’s Next for AI in Radiology?: Facilitating Data Orchestration Over Fragmentation
3
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
4
FDA Clears Machine Learning Module for Emerging Musculoskeletal Ultrasound Platform
5